PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD
ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.
AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma
The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.
The Role of Extended HPV Genotyping In Managing High Risk Patients
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds
Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.
"It Costs Too Much," Americans Say About Skipping Necessary Medical Care: Survey Findings
Affordability is pushing an increase in deferred care — even among the insured —and physicians are feeling the effects.
Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose
Your daily dose of the clinical news you may have missed.
Peripheral Artery Disease in Primary Care: Expert Insights on Recognition & Risk Factors
ACP 2025: Foluso Fakorede, MD, discusses the importance of recognizing and screening for peripheral artery disease in primary care.
New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases
New clinical trial findings to be presented at ATS 2025 highlights the effectiveness of dupilumab in treating COPD and asthma.
FDA Approves STS101 (Dihydroergotamine) Nasal Powder for Acute Treatment of Migraine
The only approved DHE nasal powder addresses persistent limitations of existing DHE formulations, including liquid nasal sprays and injectables, Satsuma stated.
Millions of US Adults Have Multiple Forms of Eczema, Study Finds
Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.
Mepolizumab Reduces AER in COPD Leading to Emergency Care by 35%: MATINEE Findings Published in NEJM
Mepolizumab also cut annualized exacerbation rates by 21% across the full study cohort and by 31% in a subgroup of participants with chronic bronchitis only.
Burden of Moderate to Severe Atopic Dermatitis Weighs Heavily on Children and Adolescents: Real-World Analysis
The burden of disease was particularly pronounced among adolescents, including significantly greater impact on quality of life and psychosocial interaction.
Low-Dose Colchicine Shrinks Plaque Volume in CAD: Daily Dose
Perceived Stress Tied to Worsened Respiratory Outcomes, Decreased QoL in Adults with COPD
Researchers reported higher levels of perceived stress were associated with worse respiratory outcomes, particularly among individuals with severe COPD.
Signs of Alzheimer Disease vs Age-Related Changes
Occasional trouble finding a word reflects typical age-related brain changes; the changes that cause a person to refer to a watch as a "hand clock" are not the same.
The Toll of Atopic Dermatitis is More than Skin Deep: Q & A with Harvard Child Psychologist Jennifer LeBovidge, PhD
Awareness of the psychological burden of eczema is improving, LeBovidge says, but if clinicians don't address mental health, patients and families will suffer in silence.
High Blood Pressure Advisory in EHR Improves Hypertension Diagnosis, Control Across a Primary Care Network
An EHR advisory that combined alerts to medical assistants with escalation to clinicians increased likelihood of hypertension control by a mean 18% per month.
Novel Study Will Monitor Brain Activity, Daily Function in People with Borderline Personality Disorder
Researchers will study brain activity and daily function in patients with BPD using wearable EEG and digital cognitive tools in a first-of-its-kind real-world study.
Loneliness Poses a Critical Barrier to Chronic Care Management
A new survey found that the loneliness linked to a diagnosis of chronic illness saps motivation to seek regular care and almost universally to take medications as prescribed.
Simple Risk Score May Guide CRC Screening Before Age 45: Daily Dose
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Millions of US Adults Have Multiple Forms of Eczema, Study Finds")
